Back to search

Article

Combination therapies delay cognitive decline over 10 years in Alzheimer’s NACC participants

2024-01-31

Abstract excerpt

<h4>INTRODUCTION</h4> Delaying cognitive decline in Alzheimer’s disease can significantly impact both function and quality of life. <h4>METHODS</h4> Longitudinal analysis of National Alzheimer’s Coordinating Center (NACC) dataset of 7,653 mild dementia CDR-SB AD participants at baseline with prescriptions for diabetes (DBMD), lipid-lowering (LIPL), anti-hypertensive (AHTN), and non-steroidal anti-inflammatory (NSD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6cd81b3e-b691-510d-af40-f806ee08ccb1
DOI
10.1101/2024.01.31.24301055
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination therapies delay cognitive decline over 10 years in Alzheimer’s NACC participantsDOI 10.1101/2024.01.31.24301055
Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialSemantic proximity
Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled TrialSemantic proximity
Precision Medicine Approach to Alzheimer’s Disease: Successful Proof-of-Concept TrialSemantic proximity
Recent Insights into Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.Semantic proximity
Treatment effects of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A systematic review overview and updated network meta-analysis.Semantic proximity
An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM.Semantic proximity
Synergistic Approaches in Neurodegenerative Therapeutics: Multi-Target Drug Innovative Interventions for Alzheimer’s DiseaseSemantic proximity
The Alzheimer’s disease drug development landscapeSemantic proximity
FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?Semantic proximity
Effect of initiating an ARB- versus ACEI-based regimen on dementia risk, a target trial emulation of 2.5 million US VeteransSemantic proximity
The Role of Statins in the Prevention and Management of Alzheimer’s Disease: A Focused ReviewSemantic proximity
Conquering Alzheimer’s: a look at the therapies of the futureSemantic proximity
Select a neighboring publication to make it the new centre.